Elderly and poor prognosis patients with high grade glioma: Hypofractionated radiotherapy

Clinica Terapeutica

Volumn 158, Issue 3, 2007, Pages 227-230

  Donato, V ^a   Monaco, Alessia ^a,b   Rollo, A ^a   Messineo, D ^a   Santuari, L ^a   Castrichino, A ^a   Caiazzo, R ^a   Salvati, M ^a   Delfini, R ^a   Banelli, E ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE   (Italy)

Author keywords

High grade glioma; Hypofractionation; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLIOMA; HUMAN; MALE; OVERALL SURVIVAL; PROGNOSIS; RADIATION DOSE; SURVIVAL TIME;

AGED; ASTROCYTOMA; BRAIN NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 34250786984     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Hulshof M, Schimmel E, Bosch DA, et al. Hypofractionation in glioblastoma multiforme. Radiother Oncol 2000; 54:143-8
2. Roa W, Brasher PM, Bauman G, et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol 2004; 22(9):1585-8
3. Slotman BJ, Kralendok JH, van Alphen HA, et al. Hypofractionated radiation therapy in patient with glioblastoma multiforme: results of treatment and impact of prognostic factors. Int J Radiat Oncol Biol Phys 1996; 34(4):895-8
4. Jeremic B, Shibamoto Y, Grujicic D, et al. Short-course radiotherapy in elderly and frail patients with glioblastoma multiforme. A phase II study. J Neuroncol 1999; 44(1):85-90
5. Glinski B. Postoperative hypofractionated radiotherapy versus conventionally fractionated radiotherapy in malignant gliomas. A preliminary report on a randomized trial. J Neurooncol 1993; 16(2):167-72
6. Thomas R, James N, Guerrero D, et al. Hypofractionated radiotherapy as palliative treatment in poor prognosis patients with high grade glioma. Radiother Oncol 1994; 33(2):113-6
7. Donato V, Valeriani M, Zurlo A. Shourt course radiation therapy for elderly cancer patients. Evidences from the literature review. Oncology/Hematology 2003; 45:305-11
8. Berg G, Blomquist E, Cavallin-Stahl E. A systematic overview of radiation therapy effects in brain tumours. Acta Oncol 2003;42(5-6): 582-8
9. Laperriere N, Zuraw L, Cairncross G. Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother Oncol 2002; 64(3):259-73
10. Jeremic B, Milicic B, Grujicic D, et al. Clinical Prognostic Factors in Patients With Malignant Glioma Treated With Combined Modality Approach Am J Clin Oncol 2004; 27:195-204
11. Kunwar S, Mohapatra G, Bollen A, et al. Genetic Subgroups of Anaplastic Astrocytomas Correlate with Patient Age and Survival. Cancer Res 2001; 61:7683-8
12. Jeremic B, Milicic B, Grujicic D, et al. Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach. J Cancer Res Clin Oncol 2003; 129:477-84
13. Batchelor TT, Betensky RA, Esposito JM, et al. Age-Dependent Prognostic Effects of Genetic Alterations in Glioblastoma. Clin Cancer Res 2004; 10:228-33
14. Crooks V, Waller S, Smith T, et al. The use of the Karnofsky Performance Scale in determining outcomes and risk in geriatric outpatients. J Gerontol 1991; 46:M139-44
15. Hollen PJ, Gralla RJ, Kris MG, et al. Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the Lung Cancer Symptom Scale. Cancer 1994; 73:2087-98
16. O'Toole DM, Golden AM. Evaluating cancer patients for rehabilitation potential. West J Med 1991; 155:384-7
17. Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: Reliability, validity, and guidelines. J Clin Oncol 1984; 2:187-93